DISCLOSEDQuarterlyRenaissance TechnologiesImmunome Inc · NASDAQ68,902 sh · $1.5MFiled 31 Mar 2026·SEC 13F·view source
DISCLOSEDStaleBlackRockImmunome Inc · NASDAQ3,758,864 sh · $45.5MFiled 30 Jun 2024·SEC 13F·view source